
Dr. Robert Koenekoop, director of the McGill Ocular Genetics Laboratory at The Montreal Children’s Hospital of the MUHC, co-led this research.
Finding genes for retinal degenerations has immediate benefits for people living with blindness and vision loss, their families, and their physicians. Establishing a genetic cause confirms the clinical diagnosis at the molecular level, helps predict the future visual prognosis, suggests therapies, and allows some patients to join clinical trials. While more than 200 genes for retinal degenerations have been identified, approximately 40-50% of cases remain a mystery. Continue reading